Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer

Head and Neck

Volumn 35, Issue 4, 2013, Pages 485-492

  Scala, L Matthew ^a,b,d   Hu, Kenneth ^a,d   Urken, Mark L ^a,d   Jacobson, Adam S ^a,d   Persky, Mark S ^a,d   Tran, Theresa N ^a,d   Smith, Mark L ^c,d   Schantz, Stimson ^c   Harrison, Louis B ^a,d  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

brachytherapy; HDR; head and neck; IORT; recurrent; salvage

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHILD; DISEASE FREE SURVIVAL; DOSE RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GLOSSECTOMY; GRAFT NECROSIS; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE RADIOTHERAPY; LARYNX CARCINOMA; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE RESECTION; MAXILLA RESECTION; MEDICAL RECORD REVIEW; MOUTH CARCINOMA; MUSCLE METASTASIS; NECK DISSECTION; OROPHARYNX CANCER; OVERALL SURVIVAL; PAROTIDECTOMY; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; REVIEW; SALIVARY GLAND CANCER; SCHOOL CHILD; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SURGICAL INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875382759     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23007     Document Type: Review

References (18)

1. McDonald MW, Lawson J, Garg MK, et al. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int J Radiat Oncol Biol Phys 2011; 80: 1292-1298.
2. Popovtzer A, Gluck I, Chepeha DB, et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 2009; 74: 1342-1347.
3. Perry DJ, Chan K, Wolden S, et al. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 76: 1140-1146.
4. Rate WR, Garrett P, Hamaker R, et al. Intraoperative radiation therapy for recurrent head and neck cancer. Cancer 1991; 67: 2738-2740.
5. Toita T, Nakano M, Takizawa Y, et al. Intraoperative radiation therapy (IORT) for head and neck cancer. Int J Radiat Oncol Biol Phys 1994; 30: 1219-1224.
6. Minimaran S,. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose. Radiat Med 2007; 25: 229-235.
7. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR,. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1995; 32: 605-609.
8. Goodwin WJ Jr,. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110 (3 Pt 2 Suppl 93): 1-18.
9. Kasperts N, Slotman BJ, Leesmans CR, de Bree R, Doornaert P, Langendijk JA,. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer 2006; 106: 1536-1547.
10. Janot F, de Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008; 26: 5518-5523.
11. Hu KS, Enker WE, Harrison LB,. High-dose-rate intraoperative irradiation: current status and future directions. Semin Radiat Oncol 2002; 12: 62-80.
12. Nag S, Schuller D, Pak V, et al. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer. Radiother Oncol 1996; 41: 125-130.
13. Nag S, Koc M, Schuller DE, Tippin D, Grecula JC,. Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers. Brachytherapy 2005; 4: 217-223.
14. Chen AM, Bucci MK, Singer MI, et al. Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience. Int J Radiat Oncol Biol Phys 2007; 67: 122-129.
15. Pellizzon AC, Salvajoli JV, Kowalski LP, Carvalho AL,. Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy. Radiat Oncol 2006; 1: 27.
16. Grabenbauer GG, Rödel C, Brunner T, et al. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. StrahlentherOnkol 2001; 177: 338-344.
17. Most MD, Allori AC, Hu K, et al. Feasibility of flap reconstruction in conjunction with intraoperative radiation therapy for advanced and recurrent head and neck cancer. Laryngoscope 2008; 118: 69-74.
18. Agra IM, Carvalho AL, Ulbrich FS, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006; 28: 107-113.